1. Kaye EM (2001). Update on genetic disorders affecting white matter. Pediatr Neurol, 24: 11–24.
2. Brown GK, Squier MV (1996). Neuropathology and pathogenesis of mitochondrial diseases. J Inher Metab Dis, 19: 553–72.
3. Blanche S, Tardieu M, Slama A, Barret B, Firtoin G, Ciraru-Vigneron, Lacroix C, Rou-zioux C, Mandelbrot L, Desguerre I, Rotig A, Mayaux MJ, DelfraissyJF (1999). Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet, 354: 1084–9.
4. Seligman AM, Karnovsky MJ, Wasserkrug HL, Hanker SJ (1968). Non-droplet ultra-structural demonstration of cytochrome oxidase activity with a polymerising osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol, 13: 1–14.
5. Sheperd D, Garland PB (1969). Citrate synthase from a liver. Methods Enzymol, 13: 11–6.